FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | Sep 17, 2026 | 0480-4015 |
| Eltrombopag | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | Sep 17, 2026 | 0480-4031 |
| Eltrombopag | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | Sep 17, 2026 | 0480-4210 |
| Cyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | Sep 17, 2026 | 59651-927 |
| Cyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | Sep 17, 2026 | 59651-928 |
| Cyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Aurobindo Pharma Limited | Sep 17, 2026 | 59651-929 |
| Ciprofloxacin Hydrochloride | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | Sep 17, 2026 | 60760-847 |
| Methocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | Sep 17, 2026 | 60760-874 |
| Esomeprazole Magnesium | Esomeprazole magnesium 20 mg/1 | Capsule, Delayed releaseOral | St. Mary's Medical Park Pharmacy | Sep 17, 2026 | 60760-877 |
| topiramate | Topiramate 50 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | Sep 17, 2026 | 60760-952 |
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | Sep 17, 2026 | 65145-194 |
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | Sep 17, 2026 | 65145-195 |
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | Sep 17, 2026 | 65145-196 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-333 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-334 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-335 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-336 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-337 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-338 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-339 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-340 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-341 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-342 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-343 |
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-344 |